DOCSLIB.ORG

Caspase Structure, Proteolytic Substrates, and Function During Apoptotic Cell Death

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Caspase Structure, Proteolytic Substrates, and Function During Apoptotic Cell Death Cell Death and Differentiation (1999) 6, 1028 ± 1042 ã 1999 Stockton Press All rights reserved 13509047/99 $15.00 http://www.stockton-press.co.uk/cdd Review Caspase structure, proteolytic substrates, and function during apoptotic cell death DW Nicholson*,1 strongly implicated ICE (or related family members, as it turned out) in a similar mammalian cell death pathway. 1 Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co., PO Importantly, this collective information also demonstrated an Box 1005, Pointe Claire ± Dorval, Quebec, Canada, H9R 4P8 essential role for specific proteolysis in apoptotic cell death, * Corresponding author: DW Nicholson Merck Frosst Centre for Therapeutic which led to the identification of proteolytic `victims' of the Research, Merck Frosst Canada & Co., PO Box 1005, Pointe Claire ± Dorval, caspases and shed light on the biochemical events that Quebec, Canada, H9R 4P8. Fax: +1 514 428-4900; E-mail: [email protected] occurred as a consequence of their cleavage. The importance of C. elegans genetics in defining the mammalian cell death Received 10.9.99; accepted 21.9.99; pathway is underscored by the fact that the individual cell Edited by G Melino death components, their molecular ordering and cellular functions have been largely conserved throughout evolu- tion6 (Figure 1). In addition to caspases, other proteases also Abstract contribute to the apoptotic cell death pathway. The serine Caspases play an essential role during apoptotic cell death. protease granzyme B, for example, has been well established These enzymes define a new class of cysteine proteases and as a caspase activator during CTL-mediated killing, and owing to its P Asp bias can function as a caspase surrogate comprise a multi-gene family with more than a dozen distinct 1 when caspases themselves are inoperative.7±9 The calpains mammalian family members. The discrete and highly limited have also been implicated in apoptosis,10 although their subset of cellular polypeptides that are cleaved by these precise role remains to be determined. proteases is sufficient to account for the majority of cellular and morphological events that occur during cell death. In some cases, caspases also play a contributory role in The mammalian caspase gene family and escalating the propensity for apoptosis, and in doing so may functional sub-families exacerbate disease pathogenesis. The caspase gene family11 thus far contains at least 14 mammalian members, of which 11 human enzymes are Keywords: apoptosis; caspase; protease; neurodegeneration known (Figure 2). A phylogenetic analysis indicates that the gene family is composed of two major sub-families which are Abbreviations: ICE, interleukin-1b converting enzyme; caspase, related to either ICE (caspase-1) or to the mammalian cysteinyl aspartate-speci®c proteinase; CED, product of cell-death- counterparts of CED-3. Further subdivisions can be made abnormal gene depending on whether the proenzymes harbour short prodomains (caspases-3, -6, -7) or long prodomains (the remainder). Alternatively, these proteases can be subdivided Proteases in apoptosis (the ICE age) on the basis of their substrate specificities which has been defined using a positional scanning combinatorial substrate ICE (interleukin-1b converting enzyme; caspase-1) is the library.12,13 Using the latter technique, the proteases fall into prototypical caspase and was initially identified as the only three specificity subgroups (Figure 3). As expected from protease responsible for the proteolytic maturation of proIL- earlier studies, the major specificity determinant is the S4 1,2 1b to its pro-inflammatory, biologically active form. When subsite (most of the enzymes are promiscuous at P2 and P3, originally discovered, ICE defined a new class of cysteinyl although they prefer His or Ile in P2 and prefer Glu in P3). proteases that was distinguishable from other cysteine Group I caspases (1, 4, 5, 13) are tolerant of liberal protease families based on general structural organization substitutions in P4 but prefer bulky hydrophobic amino acids and the absolute requirement for aspartic acid in the P1 such as Tyr or Trp. This preference is consistent with their role position of the scissile bond. A key role for ICE in inflammation in cytokine processing but does not support a substantial role had been largely established, which was quickly secured by in apoptosis since none of the polypeptides that are cleaved inhibitor studies and by the phenotype of ICE-deficient mice, during apoptosis contain hydrophobic residues in P4. The but other potential biological functions were not evident. At group II caspases (2, 3, 7) are substantially more stringent in approximately the same time, a genetic pathway for cell death S4, requiring a P4 Asp. This specificity and stringency is nearly was being defined in the nematode C. elegans.3 One of the indistinguishable from that of C. elegans CED-3. The genes in this genetic pathway, ced-3, encoded a protein that preferred cleavage motif (DExD) for group II caspases was essential for all 131 programmed cell deaths that appears in many proteins that are cleaved during cell death, occurred during hermaphrodite development. When ced-3 consistent with group II caspases being the major effectors of was cloned and sequenced, it was found to be a C. elegans cell death. Group III caspases (6, 8, 9, 10), on the other hand, 4,5 homologue of mammalian ICE. This and other evidence prefer branched chain aliphatic amino acids in P4; residues Caspase structure and role during apoptotic cell death DW Nicholson 1029 that are found at the maturation site of most group II and group APAF-1/cytochrome c pathway16 (both of these examples III caspases. This specificity is consistent with the group III have been substantiated in caspase-8 or -9 knock-out mice as enzymes being upstream activators of the group II effector well).17 ± 20 One possible exception to this general ordering caspases (Figure 4). This molecular ordering of group III and based on substrate specificity, which remains unresolved, is group II caspases has been upheld in several cases and is whether caspase-6 (a group III caspase) plays an effector role best exemplified by caspase-8-mediated activation of (e.g. lamin proteolysis)21 instead of or in addition to a putative caspase-3 and -7 in the CD95 (Fas, APO-1) system,14,15 activation role. Another exception may be caspase-2 which and caspase-9-mediated activation of caspase-3 in the appears to be a self-activating effector caspase.12,22,23 Figure 1 C. elegans cell death genetic pathway and mammalian counterparts Figure 2 The human caspase gene family. Caspases segregate into two major phylogenic sub-families (ICE, CED-3). Based on their proteolytic specificities (see Figure 3), caspases further divide into three groups: group I enzymes (blue) mediate cytokine maturation whereas the apoptotic caspases are either group II (red) effectors of cell death or group III (green) upstream activators. Most caspases have long prodomains (410 kDa) except for caspases-3, -6 and -7 (box) which have short peptidic prodomains (530 aa). With the exception of caspase-13, the human chromosomal location for all of the caspases has been determined. At least two gene clusters have been identified, consistent with some caspases arising from tandem gene duplication. These include the caspases-1, -4, -5 gene cluster on 11q22.2-q22.3 and the caspases-8, -10, cFLIP/Usurpin gene cluster on 2q33-q34.71,72 (cFLIP/Usurpin (aka CASH, Casper, CLARP, FLAME-1, I-FLICE, MRIT) is homologous to caspases -5, -8 and -10, except that substrate binding and catalytic determinants are absent, making it a dominant-negative death repressor.) The human counterparts of murine caspases-11, -12 and -14 have not yet been identified (although murine caspase-12 may be equivalent to human caspase-5) Caspase structure and role during apoptotic cell death DW Nicholson 1030 General caspase structural features which together make up the active form of the enzyme, are liberated from the proenzyme by cleavage at Asp(P1)-X(P1') Caspases are synthesized as catalytically-dormant tripartite bonds. The presence of Asp at the maturation cleavage sites proenzymes (Figure 5). Both the large and the small subunits, is consistent with the ability of caspases to auto-activate or to Figure 3 Caspase proteolytic specificity. The caspases recognize a core tetrapeptide motif corresponding to the four residues N-terminal to the scissile bond (P4- P3-P2-P1). A positional-scanning combinatorial substrate library, comprised of all 8000 possible P1 Asp tetrapeptides, segregates the caspases into three 12,13 73 specificity groups with the indicated sub-site preferences. Caspase-2 also appears to have a P5 requirement. Figure 4 Molecular ordering of caspases. Exceptions to this general ordering may also exist. Caspase-2, for example, may be self activating. Caspase-6 may function as an effector protease. Amplification circuits also exist. The caspase complement varies considerably between different cell types, directly bearing on the pathways available and how they function within different cellular environments Caspase structure and role during apoptotic cell death DW Nicholson 1031 be activated by other caspases as part of an amplification recruitment-activation (e.g. caspases-2, -8, -9, -10). Two cascade. Components of the proteolytic device, including the caspase X-ray crystal structures have been published active site Cys and His residues, are harboured within the (caspases-1 and -3)13,24 ± 27 and in both cases, the enzyme large subunit whereas residues which form the S1 subsite that was found to be a tetramer containing two large and two small tethers the carboxylate side chain of the essential P1 Asp are subunits (a [p20:p10]2 (caspase-1) or [p17:p12]2 (caspase-3) derived from both the large and small subunits (Figure 6). homodimer of the large subunit: small subunit heterodimer).
Load more

Recommended publications
  • Structure of SARS-Cov-2 Main Protease in the Apo State Reveals the 2 Inactive Conformation 3
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.12.092171; this version posted May 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Structure of SARS-CoV-2 main protease in the apo state reveals the 2 inactive conformation 3 4 Xuelan Zhoua,1, Fangling Zhongb,c,1, Cheng Lind,e, Xiaohui Hua, Yan Zhangf, Bing Xiongg, 5 Xiushan Yinh,i, Jinheng Fuj, Wei Heb, Jingjing Duank, Yang Ful, Huan Zhoum, Qisheng Wang 6 m,*, Jian Li b,c,*, Jin Zhanga,* 7 8 a School of Basic Medical Sciences, Nanchang University, Nanchang, Jiangxi, 330031, China. 9 b College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou, 341000, Jiangxi, 10 PR, China. 11 c Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases, 12 Ministry of Education, Gannan Medical University, Ganzhou 341000, PR China 13 d Shenzhen Crystalo Biopharmaceutical Co., Ltd, Shenzhen, Guangdong, 518118, China 14 e Jiangxi Jmerry Biopharmaceutical Co., Ltd, Ganzhou, Jiangxi, 341000, China. 15 f The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330031, China 16 g Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese 17 Academy of Sciences, 555 Zuchongzhi Road , Shanghai 201203 , China. 18 h Applied Biology Laboratory, Shenyang University of Chemical Technology, 110142, 19 Shenyang, China 20 i Biotech & Biomedicine Science (Jiangxi）Co. Ltd, Ganzhou, 341000, China 21 j Jiangxi-OAI Joint
    [Show full text]
  • Manner Via Caspase-8 in an RIP3
    Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1 β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner This information is current as of October 2, 2021. Lukas Bossaller, Ping-I Chiang, Christian Schmidt-Lauber, Sandhya Ganesan, William J. Kaiser, Vijay A. K. Rathinam, Edward S. Mocarski, Deepa Subramanian, Douglas R. Green, Neal Silverman, Katherine A. Fitzgerald, Ann Marshak-Rothstein and Eicke Latz Downloaded from J Immunol 2012; 189:5508-5512; Prepublished online 9 November 2012; doi: 10.4049/jimmunol.1202121 http://www.jimmunol.org/content/189/12/5508 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2012/11/12/jimmunol.120212 Material 1.DC1 References This article cites 30 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/189/12/5508.full#ref-list-1 by guest on October 2, 2021 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved.
    [Show full text]
  • The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
    Hindawi Publishing Corporation International Journal of Cell Biology Volume 2010, Article ID 215158, 21 pages doi:10.1155/2010/215158 Review Article TheRoleofCyclooxygenase-2inCellProliferationandCell Death in Human Malignancies Cyril Sobolewski,1 Claudia Cerella,1 Mario Dicato,1 Lina Ghibelli,2 and Marc Diederich1 1 LaboratoiredeBiologieMol´eculaire et Cellulaire du Cancer, Hopitalˆ Kirchberg, 9 rue Edward Steichen, 2540 Luxembourg, Luxembourg 2 Dipartimento di Biologia, Universita` di Roma di Roma Tor Vergata, Via Ricerca Scientifica snc, 00133 Rome, Italy Correspondence should be addressed to Marc Diederich, [email protected] Received 16 July 2009; Accepted 18 December 2009 Academic Editor: Simone Fulda Copyright © 2010 Cyril Sobolewski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. It is well admitted that the link between chronic inflammation and cancer involves cytokines and mediators of inflammatory pathways, which act during the different steps of tumorigenesis. The cyclooxygenases (COXs) are a family of enzymes, which catalyze the rate-limiting step of prostaglandin biosynthesis. This family contains three members: ubiquitously expressed COX- 1, which is involved in homeostasis; the inducible COX-2 isoform, which is upregulated during both inflammation and cancer; and COX-3, expressed in brain and spinal cord, whose functions remain to be elucidated. COX-2 was described to modulate cell proliferation and apoptosis mainly in solid tumors, that is, colorectal, breast, and prostate cancers, and, more recently, in hematological malignancies. These findings prompt us to analyze here the effects of a combination of COX-2 inhibitors together with different clinically used therapeutic strategies in order to further improve the efficiency of future anticancer treatments.
    [Show full text]
  • On the Active Site Thiol of Y-Glutamylcysteine Synthetase
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 2464-2468, April 1988 Biochemistry On the active site thiol of y-glutamylcysteine synthetase: Relationships to catalysis, inhibition, and regulation (glutathione/cystamine/Escherichia coli/kidney/enzyme inactivation) CHIN-SHIou HUANG, WILLIAM R. MOORE, AND ALTON MEISTER Cornell University Medical College, Department of Biochemistry, 1300 York Avenue, New York, NY 10021 Contributed by Alton Meister, December 4, 1987 ABSTRACT y-Glutamylcysteine synthetase (glutamate- dithiothreitol, suggesting that cystamine forms a mixed cysteine ligase; EC 6.3.2.2) was isolated from an Escherichia disulfide between cysteamine and an enzyme thiol (15). coli strain enriched in the gene for this enzyme by recombinant Inactivation of the enzyme by the L- and D-isomers of DNA techniques. The purified enzyme has a specific activity of 3-amino-1-chloro-2-pentanone, as well as that by cystamine, 1860 units/mg and a molecular weight of 56,000. Comparison is prevented by L-glutamate (14). Treatment of the enzyme of the E. coli enzyme with the well-characterized rat kidney with cystamine prevents its interaction with the sulfoxi- enzyme showed that these enzymes have similar catalytic prop- mines. Titration of the enzyme with 5,5'-dithiobis(2- erties (apparent Km values, substrate specificities, turnover nitrobenzoate) reveals that the enzyme has a single exposed numbers). Both enzymes are feedback-inhibited by glutathione thiol that reacts with this reagent without affecting activity but not by y-glutamyl-a-aminobutyrylglycine; the data indicate (16). 5,5'-Dithiobis(2-nitrobenzoate) does not interact with that glutathione binds not only at the glutamate binding site but the thiol that reacts with cystamine.
    [Show full text]
  • Mechanistic Insights Into the Inhibition of Prostate Specific Antigen by [Beta
    proteins STRUCTURE O FUNCTION O BIOINFORMATICS Mechanistic insights into the inhibition of prostate specific antigen by b-lactam class compounds Pratap Singh,1,2* Simon A. Williams,2 Meha H. Shah,3 Thomas Lectka,3 Gareth J. Pritchard,4 John T. Isaacs,2 and Samuel R. Denmeade1,2 1 Department of Chemical and Biomolecular Engineering, Whiting School of Engineering, The Johns Hopkins University, Baltimore, Maryland 21218 2 Chemical Therapeutics Program, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231 3 Department of Chemistry, Johns Hopkins University, Baltimore, Maryland 21218 4 Department of Chemistry, Loughborough University, Loughborough, Leicestershire LE11 3TU, United Kingdom ABSTRACT for the effect of stereochemistry of the lactam ring on the in- hibitory potency was elucidated through docking of b-lactam Prostate Specific Antigen (PSA) is a biomarker used in the enantiomers. As a validation of our docking methodology, diagnosis of prostate cancer and to monitor therapeutic two novel enantiomers were synthesized and evaluated for response. However, its precise role in prostate carcinogenesis their inhibitory potency using fluorogenic substrate based ac- and metastasis remains largely unknown. A number of stud- tivity assays. Additionally, cis enantiomers of eight b-lactam ies arguing in the favor of an active role of PSA in prostate compounds reported in a previous study were docked and cancer development and progression have implicated this their GOLD scores
    [Show full text]
  • Discovery of Endoplasmic Reticulum Calcium Stabilizers to Rescue ER-Stressed Podocytes in Nephrotic Syndrome
    Discovery of endoplasmic reticulum calcium stabilizers to rescue ER-stressed podocytes in nephrotic syndrome Sun-Ji Parka, Yeawon Kima, Shyh-Ming Yangb, Mark J. Hendersonb, Wei Yangc, Maria Lindahld, Fumihiko Uranoe, and Ying Maggie Chena,1 aDivision of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110; bNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850; cDepartment of Genetics, Washington University School of Medicine, St. Louis, MO 63110; dInstitute of Biotechnology, University of Helsinki, Helsinki, Finland 00014; and eDivision of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110 Edited by Martin R. Pollak, Beth Israel Deaconess Medical Center, Brookline, MA, and approved May 28, 2019 (received for review August 16, 2018) Emerging evidence has established primary nephrotic syndrome activating transcription factor 6 (ATF6), which act as proximal (NS), including focal segmental glomerulosclerosis (FSGS), as a sensors of ER stress. ER stress activates these sensors by inducing primary podocytopathy. Despite the underlying importance of phosphorylation and homodimerization of IRE1α and PERK/ podocyte endoplasmic reticulum (ER) stress in the pathogenesis of eukaryotic initiation factor 2α (eIF2α), as well as relocalization of NS, no treatment currently targets the podocyte ER. In our mono- ATF6 to the Golgi, where it is cleaved by S1P/S2P proteases from genic podocyte ER stress-induced NS/FSGS mouse model, the 90 kDa to the active 50-kDa ATF6 (8), leading to activation of podocyte type 2 ryanodine receptor (RyR2)/calcium release channel their respective downstream transcription factors, spliced XBP1 on the ER was phosphorylated, resulting in ER calcium leak and (XBP1s), ATF4, and p50ATF6 (8–10).
    [Show full text]
  • Molecular Markers of Serine Protease Evolution
    The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages.
    [Show full text]
  • Crystallography Captures Catalytic Steps in Human Methionine Adenosyltransferase Enzymes
    Crystallography captures catalytic steps in human methionine adenosyltransferase enzymes Ben Murraya,b, Svetlana V. Antonyuka, Alberto Marinab, Shelly C. Luc, Jose M. Matod, S. Samar Hasnaina,1, and Adriana L. Rojasb,1 aMolecular Biophysics Group, Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZX, England; bStructural Biology Unit, Center for Cooperative Research in Biosciences, 48160 Derio, Spain; cDivision of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048; and dCIC bioGUNE, CIBERehd, Parque Tecnologico Bizkaia, 801A-1.48160 Derio, Spain Edited by Gregory A. Petsko, Weill Cornell Medical College, New York, NY, and approved January 8, 2016 (received for review June 4, 2015) The principal methyl donor of the cell, S-adenosylmethionine catalytic mechanism (13, 14) in which the reaction is initiated (SAMe), is produced by the highly conserved family of methionine through a nucleophilic attack by the sulfur atom of methionine adenosyltranferases (MATs) via an ATP-driven process. These en- on the C5′ atom of ATP, which produces the intermediate tri- zymes play an important role in the preservation of life, and their polyphosphate (PPPi). Hydrolysis of the PPPi into pyrophos- dysregulation has been tightly linked to liver and colon cancers. We phate (PPi) and orthophosphate (Pi) then occurs (Fig. S1). present crystal structures of human MATα2 containing various bound A common feature of MAT enzymes is a gating loop that α – ligands, providing a “structural movie” of the catalytic steps. High- to flanks the active site (in human MAT 2 residues 113 131), atomic-resolution structures reveal the structural elements of the which has been postulated to act in a dynamic way to allow ac- enzyme involved in utilization of the substrates methionine and cess to the active site.
    [Show full text]
  • Apoptotic Threshold Is Lowered by P53 Transactivation of Caspase-6
    Apoptotic threshold is lowered by p53 transactivation of caspase-6 Timothy K. MacLachlan*† and Wafik S. El-Deiry*‡§¶ʈ** *Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, and Departments of ‡Medicine, §Genetics, ¶Pharmacology, and ࿣Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Communicated by Britton Chance, University of Pennsylvania School of Medicine, Philadelphia, PA, April 23, 2002 (received for review January 11, 2002) Little is known about how a cell’s apoptotic threshold is controlled Inhibition of the enzyme reduces the sensitivity conferred by after exposure to chemotherapy, although the p53 tumor suppres- overexpression of p53. These results identify a pathway by which sor has been implicated. We identified executioner caspase-6 as a p53 is able to accelerate the apoptosis cascade by loading the cell transcriptional target of p53. The mechanism involves DNA binding with cell death proteases so that when an apoptotic signal is by p53 to the third intron of the caspase-6 gene and transactiva- received, programmed cell death occurs rapidly. tion. A p53-dependent increase in procaspase-6 protein level al- lows for an increase in caspase-6 activity and caspase-6-specific Materials and Methods Lamin A cleavage in response to Adriamycin exposure. Specific Western Blotting and Antibodies. Immunoblotting was carried out by inhibition of caspase-6 blocks cell death in a manner that correlates using mouse anti-human p53 monoclonal (PAb1801; Oncogene), with caspase-6 mRNA induction by p53 and enhances long-term rabbit anti-human caspase-3 (Cell Signaling, Beverly, MA), mouse survival in response to a p53-mediated apoptotic signal.
    [Show full text]
  • XIAP's Profile in Human Cancer
    biomolecules Review XIAP’s Profile in Human Cancer Huailu Tu and Max Costa * Department of Environmental Medicine, Grossman School of Medicine, New York University, New York, NY 10010, USA; [email protected] * Correspondence: [email protected] Received: 16 September 2020; Accepted: 25 October 2020; Published: 29 October 2020 Abstract: XIAP, the X-linked inhibitor of apoptosis protein, regulates cell death signaling pathways through binding and inhibiting caspases. Mounting experimental research associated with XIAP has shown it to be a master regulator of cell death not only in apoptosis, but also in autophagy and necroptosis. As a vital decider on cell survival, XIAP is involved in the regulation of cancer initiation, promotion and progression. XIAP up-regulation occurs in many human diseases, resulting in a series of undesired effects such as raising the cellular tolerance to genetic lesions, inflammation and cytotoxicity. Hence, anti-tumor drugs targeting XIAP have become an important focus for cancer therapy research. RNA–XIAP interaction is a focus, which has enriched the general profile of XIAP regulation in human cancer. In this review, the basic functions of XIAP, its regulatory role in cancer, anti-XIAP drugs and recent findings about RNA–XIAP interactions are discussed. Keywords: XIAP; apoptosis; cancer; therapeutics; non-coding RNA 1. Introduction X-linked inhibitor of apoptosis protein (XIAP), also known as inhibitor of apoptosis protein 3 (IAP3), baculoviral IAP repeat-containing protein 4 (BIRC4), and human IAPs like protein (hILP), belongs to IAP family which was discovered in insect baculovirus [1]. Eight different IAPs have been isolated from human tissues: NAIP (BIRC1), BIRC2 (cIAP1), BIRC3 (cIAP2), XIAP (BIRC4), BIRC5 (survivin), BIRC6 (apollon), BIRC7 (livin) and BIRC8 [2].
    [Show full text]
  • Calpain Inhibitors Prevent Nitric Oxide-Triggered Excitotoxic Apoptosis
    Calpain inhibitors prevent nitric oxide- triggered excitotoxic apoptosis Christiane Volbracht,1,2 Eugenio Fava,1,3 Marcel Leist1,4 and Pierluigi Nicotera1,3,CA 1Molecular Toxicology, University of Konstanz, Konstanz, Germany; 2Institute of Molecular and Cell Biology, Singapore 117609, Singapore; 3MRC Toxicology Unit, University of Leicester, PO Box 138, Lancaster Road, Leicester LE1 9HN; 4Department of Neurobiology, H. Lundbeck A/S, 2500 Valby, Denmark CACorresponding Author The pathogenesis of some neurodegenerative disorders has potential, chromatin breakdown, and subsequent death of been linked to excitotoxicity, excess generation of nitric oxide cerebellar granule neurons exposed to NO donors (S-nitroso- (NO) and apoptosis. Here, we used a model of NO-triggered L-glutathione, S-nitroso-N-acetyl-D,L-penicillamine, and diethy- neuronal apoptosis that was strictly dependent on autocrine lamino-diazenolate-2-oxide). Since inhibitors did not interfere 2 NMDA receptor (NMDA-R) activation and intracellular Ca with NMDA-R activation, we suggest that block of calpains increase. We investigated the ef®ciency and potentially bene- blunts NO-triggered neuronal apoptosis by stopping the ®cial effects of calpain inhibition. Three calpain inhibitors that cascade downstream of primary autocrine excitotoxic events. prevented intracellular fodrin proteolysis also blocked apopto- NeuroReport 12:3645±3648 & 2001 Lippincott Williams & tic features such as decrease in mitochondrial membrane Wilkins. Key words: Apoptosis; Calpains; Excitotoxicity; Mitochondria; Nitric oxide INTRODUCTION MATERIALS AND METHODS Massive generation of the pleiotropic messenger molecule Cell culture: Murine CGC were isolated from 8-day-old nitric oxide (NO) has been implicated in many neuro- speci®c pathogen free BALB/e mice obtained from the pathological conditions including ischemia [1].
    [Show full text]
  • Towards Therapy for Batten Disease
    Towards therapy for Batten disease Mariana Catanho da Silva Vieira MRC Laboratory for Molecular Cell Biology University College London PhD Supervisor: Dr Sara E Mole A thesis submitted for the degree of Doctor of Philosophy University College London September 2014 Declaration I, Mariana Catanho da Silva Vieira, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract The gene underlying the classic neurodegenerative lysosomal storage disorder (LSD) juvenile neuronal ceroid lipofuscinosis (JNCL) in humans, CLN3, encodes a polytopic membrane spanning protein of unknown function. Several studies using simpler models have been performed in order to further understand this protein and its pathological mechanism. Schizosaccharomyces pombe provides an ideal model organism for the study of CLN3 function, due to its simplicity, genetic tractability and the presence of a single orthologue of CLN3 (Btn1p), which exhibits a functional profile comparable to its human counterpart. In this study, this model was used to explore the effect of different mutations in btn1 as well as phenotypes arising from complete deletion of the gene. Different btn1 mutations have different effects on the protein function, underlining different phenotypes and affecting the levels of expression of Btn1p. So far, there is no cure for JNCL and therefore it is of great importance to identify novel lead compounds that can be developed for disease therapy. To identify these compounds, a drug screen with btn1Δ cells based on their sensitivity to cyclosporine A, was developed. Positive hits from the screen were validated and tested for their ability to rescue other specific phenotypes also associated with the loss of btn1.
    [Show full text]